PROGRAM
July 11-14, 2020



DAY 1 (JULY 11)

Beijing
GMT +8
Athens
GMT +3
New York
GMT -4

Session 1 (5:30pm-7pm)

Digital health & Biomarkers

INDUSTRY SESSION

Session 2 (8:30pm-10pm)

Basics in HF: Epidemiology, clinical settings, treatments

Session 4 (5:30pm-7pm)

State of the art management of chronic HF

INDUSTRY SESSION

Session 11 (8:30pm-10pm)

Clinical trial update (part 1)

Session 7 (5:30pm-7pm)

Update on acute HF

INDUSTRY SESSION

Session 8 (8:30pm-10pm)

Update on advanced HF, assist devices and heart transplantation

DAY 2 (JULY 12)

Beijing
GMT +8
Athens
GMT +3
New York
GMT -4

Session 9 (5:30pm-7pm)

Difficult problems in HF

INDUSTRY SESSION

Session 10 (8:30pm-10pm)

New drugs and devices for HF therapy

Session 5 (5:30pm-7pm)

Co-morbidities in HF(part 1)

INDUSTRY SESSION

Session 6 (8:30pm-10pm)

Co-morbidities in HF
(part 2)

Session 12 (5:30pm-7pm)

Clinical trial update
(part 2)

INDUSTRY SESSION

Session 3 (8:30pm-10pm)

Valvular heart disease
in HF

DAY 3 (JULY 13)

Beijing
GMT +8
Athens
GMT +3
New York
GMT -4

Session 7 (5:30pm-7pm)

Update on acute HF

INDUSTRY SESSION

Session 8 (8:30pm-10pm)

Update on advanced HF, assist devices and heart transplantation

Session 1 (5:30pm-7pm)

Digital health & Biomarkers

INDUSTRY SESSION

Session 2 (8:30pm-10pm)

Basics in HF: Epidemiology, clinical settings, treatments

Session 4 (5:30pm-7pm)

State of the art management of chronic HF

INDUSTRY SESSION

Session 11 (8:30pm-10pm)

Clinical trial update (part 1)

DAY 4 (JULY 14)

Beijing
GMT +8
Athens
GMT +3
New York
GMT -4

Session 6 (5:30pm-7pm)

Co-morbidities in HF
(part 2)

INDUSTRY SESSION

Session 5 (8:30pm-10pm)

Co-morbidities in HF(part 1)

Session 12 (5:30pm-7pm)

Clinical trial update
(part 2)

INDUSTRY SESSION

Session 3 (8:30pm-10pm)

Valvular heart disease
in HF

Session 10 (5:30pm-7pm)

New drugs and devices for HF therapy

INDUSTRY SESSION

Session 9 (8:30pm-10pm)

Difficult problems in HF

Looking to register a group of 10 or more? contact: “[email protected]”.

Thank You!